Angel maintains BUY rating on Sun Pharma despite 11 US FDA observations
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Infibeam Inc. to hold AGM

- business-standard

Angel maintains BUY rating on Sun Pharma despite 11 US FDA observations

Angel Broking maintained its BUY rating on Sun Pharmaceutical Industries with a price target of Rs 847, even as the pharma major received 11 observations the US Food and Drug Administration (FDA) for its Dadra unit. The post Angel maintains BUY rating on S

Read on the original site


Higher opening on the cards

- business-standard

Cracks appear on Umiam bridge

- heshillongtimes.com

NGT violation

- heshillongtimes.com

Assam Rifles denies abuse incident

- heshillongtimes.com
Hashtags:   

Angel

 | 

maintains

 | 

BUY

 | 

rating

 | 

Sun

 | 

Pharma

 | 

despite

 | 

FDA

 | 

observations

 |